| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,568,000 | 2,536,000 | 2,504,000 | 1,069,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 2,536,000 | 2,504,000 | 1,069,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,159,000 | 2,652,000 | 1,783,000 | 1,104,000 | | Non Recurring |
-
|
-
|
-
| 277,000 | | Others | (680,000) | (176,000) | 1,458,000 | (1,296,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (217,000) | 60,000 | (737,000) | 984,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 89,000 | 60,000 | (737,000) | 984,000 | | Interest Expense | 96,000 | 114,000 | 96,000 | 1,416,000 | | Income Before Tax | (7,000) | (54,000) | (833,000) | (432,000) | | Income Tax Expense | (52,000) | (4,000) | (364,000) | (111,000) | | Minority Interest | (26,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 45,000 | (50,000) | (469,000) | (321,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,000 | (50,000) | (469,000) | (321,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,000 | ($50,000) | ($469,000) | ($321,000) |
|
0.20% Nasdaq 
0.14%
Income Statement
